Sanyou Bio secures RMB 100 million in a Series C funding round led by Zero2IPO Industry Investment, enhancing its innovative drug R&D capabilities.
Nov 09, 2026
Amount Raised
¥100 Million
Round Type
Series C
ShanghaiBiotechnology
Investors
Zero2IPO Industry Investment
Description
Sanyou Biopharmaceuticals Co., Ltd. has announced the completion of a Series C financing round worth nearly RMB 100 million, exclusively funded by Zero2IPO Industry Investment. This successful financing reflects strong recognition of Sanyou Bio's technological capabilities and growth potential. The funds will accelerate its development in the field of AI-driven innovative drug R&D and commercialization.
Who to call at SanyouBio, and when
A new round usually means SanyouBio is about to hire and buy. The teams that reach out first get the meeting.
An alert the day SanyouBio raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at SanyouBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SanyouBio. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
SanyouBio
Location
Shanghai, China
About
Sanyou Biopharmaceuticals Co., Ltd. is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biologic drugs. The company has built a 4C business model integrating differentiated CRO, integrated CDO, innovative CPO, and characteristic CRS. Their mission is to simplify the R&D process for innovative biologics. Sanyou has established an advanced R&D laboratory and has a professional team with many members holding Ph.D. or master's degrees.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SanyouBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ShanghaiBiotechnology